Literature DB >> 26623421

Abnormally high level of CA-19-9 in a benign ovarian cyst.

Seung-Yeon Pyeon1, Ji Young Park1, Kyung-Do Ki1, Jong-Min Lee1.   

Abstract

CA-19-9 antigen is mainly elevated in cases of gastrointestinal tract malignancy, including of the pancreas, colorectum, and biliary tract. CA 19-9 antigen can also be elevated in ovarian mucinous neoplasms, however, as well as in many benign conditions. Markedly raised levels of more than 10,000 U/mL were almost observed in advanced stage of malignancy. We report herein the case of a 37-year-old woman who presented with an abnormally high level of CA 19-9 antigen associated with benign mucinous cystadenoma.

Entities:  

Keywords:  CA 19-9 antigen; Cystadenoma, mucinous; Tumor markers, biological

Year:  2015        PMID: 26623421      PMCID: PMC4663235          DOI: 10.5468/ogs.2015.58.6.530

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN: 2287-8572


  10 in total

1.  Elevated carbohydrate antigen 19-9 in a dermoid cyst.

Authors:  C Atabekoğlu; E A Bozaci; S Tezcan
Journal:  Int J Gynaecol Obstet       Date:  2005-09-15       Impact factor: 3.561

2.  Increased serum carcinomic antigen 19-9(CA 19-9) in a dermoid cyst.

Authors:  S Nanayakkara; S Ali; K Gilmour
Journal:  J Obstet Gynaecol       Date:  2007-01       Impact factor: 1.246

3.  A study of ovarian cancer biomarker amplification using ultrasound for early stage detection.

Authors:  Danhong Peng; Tian Xu; Timothy J Mason; Wei Wu
Journal:  Ultrasonics       Date:  2013-06-20       Impact factor: 2.890

4.  Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.

Authors:  Paul J Kelly; Pooler Archbold; John H Price; Chris Cardwell; W Glenn McCluggage
Journal:  J Clin Pathol       Date:  2010-02       Impact factor: 3.411

Review 5.  The clinical utility of the CA 19-9 tumor-associated antigen.

Authors:  W Steinberg
Journal:  Am J Gastroenterol       Date:  1990-04       Impact factor: 10.864

6.  Specific antigen in serum of patients with colon carcinoma.

Authors:  H Koprowski; M Herlyn; Z Steplewski; H F Sears
Journal:  Science       Date:  1981-04-03       Impact factor: 47.728

7.  Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.

Authors:  K Kudoh; Y Kikuchi; T Kita; T Tode; M Takano; J Hirata; Y Mano; K Yamamoto; I Nagata
Journal:  Gynecol Obstet Invest       Date:  1999       Impact factor: 2.031

Review 8.  Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection.

Authors:  J S Berek; R C Bast
Journal:  Cancer       Date:  1995-11-15       Impact factor: 6.860

9.  Unusually High Levels of CA19-9 Associated with Mature Cystic Teratoma of the Ovary.

Authors:  Monika Madaan; Manju Puri; Ritu Sharma; Harvinder Kaur; Shubha Sagar Trivedi
Journal:  Case Rep Obstet Gynecol       Date:  2014-09-08

10.  Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study.

Authors:  Hye-Yon Cho; Min Sun Kyung
Journal:  Med Sci Monit       Date:  2014-07-30
  10 in total
  6 in total

1.  Unusually High Serum Levels of CA 19-9 in an Ovarian Tumour: Malignant or Benign?

Authors:  Divya Pandey; Ritu Sharma; Shakti Sharma; Sudha Salhan
Journal:  J Clin Diagn Res       Date:  2017-03-01

2.  A giant ovarian mucinous tumor in a 58-year-old postmenopausal patient with persistent abdominal pain and high serum levels of CA 19-9.

Authors:  Francesk Mulita; Nikoleta Oikonomou; Levan Tchabashvili; Elias Liolis; Ioannis Kehagias
Journal:  Pan Afr Med J       Date:  2020-09-18

Review 3.  Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 72-4 in Gastric Cancer: Is the Old Band Still Playing?

Authors:  Andrey Iskrenov Kotzev; Peter Vassilev Draganov
Journal:  Gastrointest Tumors       Date:  2018-04-24

4.  Correlation between serum carbohydrate antigen 19-9 levels and computed tomography severity score in patients with nontuberculous mycobacterial pulmonary disease.

Authors:  Kangjoon Kim; Seung Hyun Yong; Su Hwan Lee; Sang Hoon Lee; Ah Young Leem; Song Yee Kim; Kyungsoo Chung; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Hye-Jeong Lee; Young Ae Kang
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

5.  Extreme elevation of CA 19-9 levels in mature cystic teratoma without any complications: A case report.

Authors:  Angela Cho; Bo Ram Kim; So Hyun Lim; Chul Min Park
Journal:  Ann Med Surg (Lond)       Date:  2022-05-18

6.  Serum CA19-9, CA-125 and CEA as tumor markers for mucinous ovarian tumors.

Authors:  Arb-Aroon Lertkhachonsuk; Supree Buranawongtrakoon; Navamol Lekskul; Naparat Rermluk; Wei-Wei Wee-Stekly; Chuenkamon Charakorn
Journal:  J Obstet Gynaecol Res       Date:  2020-08-23       Impact factor: 1.730

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.